CN1319660A - Human testis specific protein kinase gene coding protein - Google Patents
Human testis specific protein kinase gene coding protein Download PDFInfo
- Publication number
- CN1319660A CN1319660A CN 01113510 CN01113510A CN1319660A CN 1319660 A CN1319660 A CN 1319660A CN 01113510 CN01113510 CN 01113510 CN 01113510 A CN01113510 A CN 01113510A CN 1319660 A CN1319660 A CN 1319660A
- Authority
- CN
- China
- Prior art keywords
- gene
- nyd
- spk
- fusion protein
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 39
- 101000797917 Homo sapiens 1,5-anhydro-D-fructose reductase Proteins 0.000 title claims abstract description 18
- 102000004169 proteins and genes Human genes 0.000 title abstract description 9
- 108020001507 fusion proteins Proteins 0.000 claims abstract description 13
- 102000037865 fusion proteins Human genes 0.000 claims abstract description 12
- 230000014509 gene expression Effects 0.000 claims abstract description 9
- 108700026244 Open Reading Frames Proteins 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- 201000010099 disease Diseases 0.000 claims abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 6
- 239000003814 drug Substances 0.000 claims abstract description 6
- 229940079593 drug Drugs 0.000 claims abstract description 6
- 239000002299 complementary DNA Substances 0.000 claims abstract description 3
- 210000001550 testis Anatomy 0.000 claims description 14
- 238000002965 ELISA Methods 0.000 claims description 5
- 239000002671 adjuvant Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 210000004027 cell Anatomy 0.000 claims description 3
- 210000004408 hybridoma Anatomy 0.000 claims description 3
- 241000699670 Mus sp. Species 0.000 claims description 2
- 241000283977 Oryctolagus Species 0.000 claims description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 2
- 230000003053 immunization Effects 0.000 claims description 2
- 201000000050 myeloid neoplasm Diseases 0.000 claims description 2
- 230000003248 secreting effect Effects 0.000 claims description 2
- 210000000952 spleen Anatomy 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 210000003719 b-lymphocyte Anatomy 0.000 claims 1
- 238000010367 cloning Methods 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 abstract description 3
- 241001465754 Metazoa Species 0.000 abstract description 2
- 238000012215 gene cloning Methods 0.000 abstract 2
- 230000002381 testicular Effects 0.000 abstract 1
- 108091000080 Phosphotransferase Proteins 0.000 description 6
- 102000020233 phosphotransferase Human genes 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 102100032386 1,5-anhydro-D-fructose reductase Human genes 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 239000012528 membrane Substances 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 108060006633 protein kinase Proteins 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 108010078791 Carrier Proteins Proteins 0.000 description 2
- 101000864825 Homo sapiens Doublesex- and mab-3-related transcription factor 3 Proteins 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241000237988 Patellidae Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- UYCAGRPOUWSBIQ-WOYAITHZSA-N [(1s)-1-carboxy-4-(diaminomethylideneamino)butyl]azanium;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound OC(=O)[C@@H]1CCC(=O)N1.OC(=O)[C@@H](N)CCCN=C(N)N UYCAGRPOUWSBIQ-WOYAITHZSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000007877 drug screening Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000011532 immunohistochemical staining Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 238000009007 Diagnostic Kit Methods 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 101000988834 Homo sapiens Hypoxanthine-guanine phosphoribosyltransferase Proteins 0.000 description 1
- 102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 102100026918 Phospholipase A2 Human genes 0.000 description 1
- 108010058864 Phospholipases A2 Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- 102000004282 Ribosomal protein S9 Human genes 0.000 description 1
- 108090000878 Ribosomal protein S9 Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 230000003509 anti-fertility effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000006957 competitive inhibition Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000012224 gene deletion Methods 0.000 description 1
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000023508 male gonad development Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明属于人类基因组技术领域,所述的人睾丸特异蛋白激酶基因(testis specific protein kinase gene,NYD-SPK)基因全长cDNA序列为3617 bp,其开放阅读框序列为2991 bp,其编码966个氨基酸,该基因在基因库(Genbank)中的编号为AF332194。本发明利用NYD-SPK基因克隆制备融合蛋白,并可用该蛋白免疫动物制备单克隆和多克隆抗体,同时可将基因克隆用于睾丸特异功能基因表达芯片的制备,表达蛋白也可能成为治疗相关疾病的基因药物。The invention belongs to the field of human genome technology. The full-length cDNA sequence of the human testis specific protein kinase gene (NYD-SPK) gene is 3617 bp, its open reading frame sequence is 2991 bp, and it encodes 966 Amino acid, the number of this gene in Genbank (Genbank) is AF332194. The present invention uses NYD-SPK gene cloning to prepare fusion protein, and the protein can be used to immunize animals to prepare monoclonal and polyclonal antibodies. At the same time, gene cloning can be used for the preparation of testicular specific function gene expression chips, and the expressed protein may also be used to treat related diseases. gene medicines.
Description
本发明属于人类基因组技术领域。The invention belongs to the technical field of human genome.
本发明所述人睾丸特异的蛋白激酶基因(testis specificprotein kinase gene,NYD-SPK)是发明人在南京医科大学生殖医学江苏省重点实验室用基因芯片方法筛选获得,首先制备人睾丸功能基因表达芯片,通过比较胚胎和成年人睾丸功能基因的表达,获得差异表达克隆,经序列测定证明为全长cDNA,为3617 bp;其开放阅读框架为2991 bp,其编码996个氨基酸。查阅基因库,该基因为新基因,具有酪氨酸,丝氨酸磷酸化激酶活性。由于该基因是成人睾丸高表达,因此发现的人睾丸特异的蛋白激酶基因可能与睾丸发育有关,用该基因克隆可制备成融合蛋白,用该蛋白免疫家兔,可获得单克隆和多克隆抗体,该基因也可用于制备睾丸功能基因表达芯片。融合蛋白也可能成为治疗相关疾病的基因药物。The human testis-specific protein kinase gene (testis specific protein kinase gene, NYD-SPK) of the present invention was obtained by the inventor in the Key Laboratory of Reproductive Medicine, Jiangsu Province, Nanjing Medical University, through gene chip method screening, and first prepared a human testis functional gene expression chip , By comparing the expression of embryonic and adult testis functional genes, a differentially expressed clone was obtained, which was proved to be a full-length cDNA of 3617 bp by sequence determination; its open reading frame was 2991 bp, and it encoded 996 amino acids. Check the gene bank, the gene is a new gene, has tyrosine, serine phosphorylation kinase activity. Since this gene is highly expressed in adult testis, the human testis-specific protein kinase gene discovered may be related to testis development. This gene clone can be used to prepare a fusion protein, and the protein can be used to immunize rabbits to obtain monoclonal and polyclonal antibodies. , the gene can also be used to prepare testis functional gene expression chip. Fusion proteins may also become gene medicines for treating related diseases.
由于人睾丸特异蛋白激酶基因在Genbank数据库中尚无人的同源基因,本发明人对于该基因的结构和功能研究成果全都是开创性的。美国国家生物技术情报中心(National Center for BiotechnologyInformation,NCBI)已正式接受该基因为Genbank的新成员,接受号为AF332194。1 ggaaaagtgt gaggtcagta gtagtttttg tggtacgtgc agtggtggcc gcttcaagga61 ctattttcgt cgctgcttgc gttttaagtc tccaatcctg ggacgaggcc catttcaggg121 ttttctgtca ccttctagcc gcccgccacc ccagaggggt gccagatgcc ccagtttttg181 agtgcatgca ggcaggcgaa agtggctcga aaagacctcc ggcctgaatg atctccatga241 agacgcggtc acgcagcctc cacactctct tccccttctc gaaaattctg tgccatttaa301 gtttcaaaat cccttataaa ataagtgtca gagagctacg tgtacccgtt tcttccaaat361 tttcatcacg aagtggagat ttggacgtac tattttgtga tctctgtttg cagaaagtgg421 gtacggcatc agtgccttca taatcaggtt tttcaggaat tgttcagatg gatgaagata481 cacattacga taaagtggaa gatgtggttg gaagtcacat agaagatgca gtaacatttt541 gggcccagag tatcaataga aataaggata tcatgaagat tggttgctca ctgtctgaag601 tttgccccca ggccagttca gttttgggga atcttgaccc aaacaagatt tatggtggat661 tattttctga agatcagtgt tggtacagat gcaaagtact gaaaatcatc agcgttgaaa721 agtgtctggt gaggtacatt gactatggaa atactgaaat tctaaatcga tctgatatag781 ttgaaattcc tttggagctg cagttttcta gtgttgccaa aaagtataaa ctttggggac841 tacacattcc ttctgatcaa gaagttaccc agtttgatca gggcacaacc tttttgggga901 gcttgatttt tgaaaaggaa ataaaaatga gaattaaagc aacctctgaa gatggaacag961 ttattgctca ggctgagtat ggcagtgtgg atatagggga agaggtgctt aagaaaggat1021 ttgcagagaa atgcagactt gcttccagaa ctgacatctg tgaggaaaaa aaattggatc1081 ctggtcaact tgttctcagg aacctcaaaa gccccattcc tttgtggggg catagatcaa1141 accagtcaac cttcagcagg cccaaggggc acttaagtga gaaaatgact cttgacttga1201 aggatgaaaa tgatgcaggc aatcttataa catttccaaa ggaaagtttg gctgttggtg1261 actttaattt agggtctaac gtcagcctgg aaaaatttaa gcaggaccag aaactgattg1321 aagaaaatga aaaacttaaa acagagaagg acgctcttct tgaaagttat aaggcgttag1381 aattgaaagt agagcagatt gcccaggagc tgcagcaaga gaaggcagct gctgtggatt1441 tgactaacca cttagaatac actctgaaga cctatataga taccagaatg aaaaatctgg1501 cagctaagat ggaaatactg aaagaaatga ggcatgtcga catcagtgtc cgtttcggaa1561 aagacctttc agatgctata caagtgttgg atgaagggtg ctttactact ccagcttctt1621 tgaacggatt agagataata tgggcagaat acagtctggc tcaggagaat attaaaactt1681 gtgaatatgt gagtgaaggg aatattttga ttgcccaaag aaatgaaatg cagcagaagc1741 tgtacatgtc agtagaagat tttattctgg aagttgatga gtcatctctt aataaacgct1801 taaaaacatt gcaggatttg tcagtctctt tagaagcagt gtatggacaa gccaaagaag1861 gagcaaattc tgatgaaata cttaaaaaat tttatgactg gaagtgtgat aaaagagagg1921 agtacaccag tgttagaagt gaaacagacg cttctctgca ccgtcttgta gcatggttcc1981 aaagaacctt aaaggttttt gacctatctg tggaaggatc actgatttca gaagacgcaa2041 tggataatat tgatgaaatc ctagagaaga ctgagtcaag tgtctgcaaa gagctggaga2101 tagctctggt tgatcaaggt gatgcagaca aggagataat ttcaaataca tatagtcaag2161 tactgcaaaa gattcattca gaggaaaggc tcattgccac agtacaagct aagtacaagg2221 acagtattga gtttaaaaag cagcttattg aatatttaaa taagagtccc agtgtggatc2281 acttgctatc cattaagaag acattgaaaa gcttaaaagc tctactcaga tggaaattgg2341 ttgaaaagag taatttggaa gagtcagatg atcctgatgg ctctcaaatt gagaaaataa2401 aagaagaaat aactcagctg cgcaataatg tctttcagga aatttatcat gagagagagg2461 aatatgagat gctaactagt ttggcacaga aatggttccc tgagctgcct ctgcttcatc2521 ctgaaatagg attactcaaa tgcatgaact ctggtggtct ccttacaatg agcttggaac2581 gagatcttct tgatgctgag cccatgaagg aacttagcag caagcgtcct ttggtacgtt2641 ctgaggttaa tgggcagata attctgttaa agggctattc tgtggatgtt gacacagaag2701 ccaaggtgat tgagagagca gccacctacc atagagcttg gagagaagct gaaggagact2761 cagggttact gccattgata ttcctgtttt tatgtaagtc tgatcctatg gcttatctga2821 tggtcccata ctaccctagg gcaaacctga atgctgctca agccaacatg cctttaaatt2881 cagaagaaac tttaaaggtc atgaaaggtg ttgcccaggg tctgcataca ttgcataagg2941 ctgacataat tcatggatca cttcatcaga acaatgtatt tgctttaaac cgtgaacaag3001 gaattgttgg agattttgac ttcaccaaat ctgtgagtca gcgagcctcg gtgaacatga3061 tggttggtga cttgagtttg atgtcacctg agttgaaaat gggaaaacct gcttctccag3121 gttcagactt atatgcttat ggctgcctct tattatggct ttctgttcaa aatcaggagt3181 ttgagataaa taaagatgga atccccaaag tggatcagtt tcatttggat gataaagtca3241 tatccctcct ctgtagcttg atatgttata gaagttcaat gactggtgaa caagttttaa3301 atgctgaatg tttcttgatg ccaaaggagc aatcagttcc aaacccagaa aaagatactg3361 aatacaccct atataaaaag gaagaagaaa taaagccgga gaatttggat aaatgtatgg3421 agaagacaag aaatggtgaa gccaactttg attgttaaat tattattgtt gttgttgcaa3481 aggttctttt taaaaacttt gtttggtttg gttaatacac agaaatatct agaaatgttc3541 tgggactagt tgagttgtat ctttagtatt caggttgtga aaaataaaga tgtttggcta3601 tgcgcttaaa aaaaaaaSince the human testis-specific protein kinase gene has no homologous gene in the Genbank database, the inventors' research results on the structure and function of the gene are all groundbreaking.美国国家生物技术情报中心(National Center for BiotechnologyInformation,NCBI)已正式接受该基因为Genbank的新成员,接受号为AF332194。1 ggaaaagtgt gaggtcagta gtagtttttg tggtacgtgc agtggtggcc gcttcaagga61 ctattttcgt cgctgcttgc gttttaagtc tccaatcctg ggacgaggcc catttcaggg121 ttttctgtca ccttctagcc gcccgccacc ccagaggggt gccagatgcc ccagtttttg181 agtgcatgca ggcaggcgaa agtggctcga aaagacctcc ggcctgaatg atctccatga241 agacgcggtc acgcagcctc cacactctct tccccttctc gaaaattctg tgccatttaa301 gtttcaaaat cccttataaa ataagtgtca gagagctacg tgtacccgtt tcttccaaat361 tttcatcacg aagtggagat ttggacgtac tattttgtga tctctgtttg cagaaagtgg421 gtacggcatc agtgccttca taatcaggtt tttcaggaat tgttcagatg gatgaagata481 cacattacga taaagtggaa gatgtggttg gaagtcacat agaagatgca gtaacatttt541 gggcccagag tatcaataga aataaggata tcatgaagat tggttgctca ctgtctgaag601 tttgccccca ggccagttca gttttgggga atcttgaccc aaacaagatt tatggtggat661 tattttctga agatcagtgt tggtacagat gcaaagtact gaaaatcatc agcgttgaaa721 agtgtctggt gaggtacatt gactatggaa atactgaaat tctaaatcga tctgatatag781 ttgaaattcc tttggagctg cagttttcta gtgttgccaa aaagtataaa ctttggggac841 tacacattcc ttctgatcaa gaagttaccc agtttgatca gggcacaacc tttttgggga901 gcttgatttt tgaaaaggaa ataaaaatga gaattaaagc aacctctgaa gatggaacag961 ttattgctca ggctgagtat ggcagtgtgg atatagggga agaggtgctt aagaaaggat1021 ttgcagagaa atgcagactt gcttccagaa ctgacatctg tgaggaaaaa aaattggatc1081 ctggtcaact tgttctcagg aacctcaaaa gccccattcc tttgtggggg catagatcaa1141 accagtcaac cttcagcagg cccaaggggc acttaagtga gaaaatgact cttgacttga1201 aggatgaaaa tgatgcaggc aatcttataa catttccaaa ggaaagtttg gctgttggtg1261 actttaattt agggtctaac gtcagcctgg aaaaatttaa gcaggaccag aaactgattg1321 aagaaaatga aaaacttaaa acagagaagg acgctcttct tgaaagttat aaggcgttag1381 aattgaaagt agagcagatt gcccaggagc tgcagcaaga gaaggcagct gctgtggatt1441 tgactaacca cttagaatac actctgaaga cctatataga taccagaatg aaaaatctgg1501 cagctaagat ggaaatactg aaagaaatga ggcatgtcga catcagtgtc cgtttcggaa1561 aagacctttc agatgctata caagtgttgg atgaagggtg ctttactact ccagcttctt1621 tgaacggatt agagataata tgggcagaat acagtctggc tcaggagaat attaaaactt1681 gtgaatatgt gagtgaaggg aatattttga ttgcccaaag aaatgaaatg cagcagaagc1741 tgtacatgtc agtagaagat tttattctgg aagttgatga gtcatctctt aataaacgct1801 taaaaacatt gcaggatttg tcagtctctt tagaagcagt gtatggacaa gccaaagaag1861 gagcaaattc tgatgaaata cttaaaaaat tttatgactg gaagtgtgat aaaagagagg1921 agtacaccag tgttagaagt gaaacagacg cttctctgca ccgtcttgta gcatggttcc1981 aaagaacctt aaaggttttt gacctatctg tggaaggatc actgatttca gaagacgcaa2041 tggataatat tgatgaaatc ctagagaaga ctgagtcaag tgtctgcaaa gagctggaga2101 tagctctggt tgatcaaggt gatgcagaca aggagataat ttcaaataca tatagtcaag2161 tactgcaaaa gattcattca gaggaaaggc tcattgccac agtacaagct aagtacaagg2221 acagtattga gtttaaaaag cagcttattg aatatttaaa taagagtccc agtgtggatc2281 acttgctatc cattaagaag acattgaaaa gcttaaaagc tctactcaga tggaaattgg2341 ttgaaaagag taatttggaa gagtcagatg atcctgatgg ctctcaaatt gagaaaataa2401 aagaagaaat aactcagctg cgcaataatg tctttcagga aatttatcat gagagagagg2461 aatatgagat gctaactagt ttggcacaga aatggttccc tgagctgcct ctgcttcatc2521 ctgaaatagg attactcaaa tgcatgaact ctggtggtct ccttacaatg agcttggaac2581 gagatcttct tgatgctgag cccatgaagg aacttagcag caagcgtcct ttggtacgtt2641 ctgaggttaa tgggcagata attctgttaa agggctattc tgtggatgtt gacacagaag2701 ccaaggtgat tgagagagca gccacctacc atagagcttg gagagaagct gaaggagact2761 cagggttact gccattgata ttcctgtttt tatgtaagtc tgatcctatg gcttatctga2821 tggtcccata ctaccctagg gcaaacctga atgctgctca agccaacatg cctttaaatt2881 cagaagaaac tttaaaggtc atgaaaggtg ttgcccaggg tctgcataca ttgcataagg2941 ctgacataat tcatggatca cttcatcaga acaatgtatt tgctttaaac cgtgaacaag3001 gaattgttgg agattttgac ttcaccaaat ctgtgagtca gcgagcctcg gtgaacatga3061 tggttggtga cttgagtttg atgtcacctg agttgaaaat gggaaaacct gcttctccag3121 gttcagactt atatgcttat ggctgcctct tattatggct ttctgttcaa aatcaggagt3181 ttgagataaa taaagatgga atccccaaag tggatcagtt tcatttggat gataaagtca3241 tatccctcct ctgtagcttg atatgttata gaagttcaat gactggtgaa caagttttaa3301 atgctgaatg tttcttgatg ccaaaggagc aatcagttcc aaacccagaa aaagatactg3361 aatacaccct atataaaaag gaagaagaaa taaagccgga gaatttggat aaatgtatgg3421 agaagacaag aaatggtgaa gccaactttg attgttaaat tattattgtt gttgttgcaa3481 aggttctttt taaaaacttt gtttggtttg gttaatacac agaaatatct agaaatgttc3541 tgggactagt tgagttgtat ctttagtatt caggttgtga aaaataaaga tgtttggcta3601 tgcgcttaaa aaaaaaa
人睾丸激酶基因cDNA序列MDEDTHYDKVEDVVGSHIEDAVTFWAQSINRNKDIMKIGCSLSEVCPQASSVLGNLDPNKIYGGLFSEDQCWYRCKVLKIISVEKCLVRYIDYGNTEILNRSDIVEIPLELQFSSVAKKYKLWGLHIPSDQEVTQFDQGTTFLGSLIFEKEIKMRIKATSEDGTVIAQAEYGSVDIGEEVLKKGFAEKCRLASRTDICEEKKLDPGQLVLRNLKSPIPLWGHRSNQSTFSRPKGHLSEKMTLDLKDENDAGNLITFPKESLAVGDFNLGSNVSLEKFKQDQKLIEENEKLKTEKDALLESYKALELKVEQIAQELQQEKAAAVDLTNHLEYTLKTYIDTRMKNLAAKMEILKEMRHVDISVRFGKDLSDAIQVLDEGCFTTPASLNGLEIIWAEYSLAQENIKTCEYVSEGNILIAQRNEMQQKLYMSVEDFILEVDESSLNKRLKTLQDLSVSLEAVYGQAKEGANSDEILKKFYDWKCDKREEYTSVRSETDASLHRLVAWFQRTLKVFDLSVEGSLISEDAMDNIDEILEKTESSVCKELEIALVDQGDADKEIISNTYSQVLQKIHSEERLIATVQAKYKDSIEFKKQLIEYLNKSPSYDHLLSIKKTLKSLKALLRWKLVEKSNLEESDDPDGSQIEKIKEEITQLRNNVFQEIYHEREEYEMLTSLAQKWFPELPLLHPEIGLLKCMNSGGLLTMSLERDLLDAEPMKELSSKRPLVRSEVNGQIILLKGYSVDVDTEAKVIERAATYHRAWREAEGDSGLLPLIFLFLCKSDPMAYLMVPYYPRANLNAAQANMPLNSEETLKVMKGVAQGLHTLHKADIIHGSLHQNNVFALNREQGIVGDFDFTKSVSQRASVNMMVGDLSLMSPELKMGKPASPGSDLYAYGCLLLWLSVQNQEFEINKDGIPKYDQFHLDDKVISLLCSLICYRSSMTGEQVLNAECFLMPKEQSVPNPEKDTEYTLYKKEEEIKPENLDKCMEKTRNGEANFDC人睾丸激酶基因cDNA序列MDEDTHYDKVEDVVGSHIEDAVTFWAQSINRNKDIMKIGCSLSEVCPQASSVLGNLDPNKIYGGLFSEDQCWYRCKVLKIISVEKCLVRYIDYGNTEILNRSDIVEIPLELQFSSVAKKYKLWGLHIPSDQEVTQFDQGTTFLGSLIFEKEIKMRIKATSEDGTVIAQAEYGSVDIGEEVLKKGFAEKCRLASRTDICEEKKLDPGQLVLRNLKSPIPLWGHRSNQSTFSRPKGHLSEKMTLDLKDENDAGNLITFPKESLAVGDFNLGSNVSLEKFKQDQKLIEENEKLKTEKDALLESYKALELKVEQIAQELQQEKAAAVDLTNHLEYTLKTYIDTRMKNLAAKMEILKEMRHVDISVRFGKDLSDAIQVLDEGCFTTPASLNGLEIIWAEYSLAQENIKTCEYVSEGNILIAQRNEMQQKLYMSVEDFILEVDESSLNKRLKTLQDLSVSLEAVYGQAKEGANSDEILKKFYDWKCDKREEYTSVRSETDASLHRLVAWFQRTLKVFDLSVEGSLISEDAMDNIDEILEKTESSVCKELEIALVDQGDADKEIISNTYSQVLQKIHSEERLIATVQAKYKDSIEFKKQLIEYLNKSPSYDHLLSIKKTLKSLKALLRWKLVEKSNLEESDDPDGSQIEKIKEEITQLRNNVFQEIYHEREEYEMLTSLAQKWFPELPLLHPEIGLLKCMNSGGLLTMSLERDLLDAEPMKELSSKRPLVRSEVNGQIILLKGYSVDVDTEAKVIERAATYHRAWREAEGDSGLLPLIFLFLCKSDPMAYLMVPYYPRANLNAAQANMPLNSEETLKVMKGVAQGLHTLHKADIIHGSLHQNNVFALNREQGIVGDFDFTKSVSQRASVNMMVGDLSLMSPELKMGKPASPGSDLYAYGCLLLWLSVQNQEFEINKDGIPKYDQFHLDDKVISLLCSLICYRSSMTGEQVLNAECFLMPKEQSVPNPEKDTEYTLYKKEEEIKPENLDKCMEKTRNGEANFDC
人睾丸特异的蛋白激酶基因开放阅读框架氨基酸序列The open reading frame amino acid sequence of human testis-specific protein kinase gene
本发明的目的是:鉴于人睾丸特异的蛋白激酶基因是本发明人发现的全新基因,目前人类对此基因的认识和了解仅限于本发明人所做的科学研究工作。由于该基因是与睾丸特异功能相关的基因,而且是胚胎低表达,成人高表达,因此该基因很可能与睾丸发育有关,其异常表达可能影响男性的生殖功能,因此该基因的研究可用于:①通过制备该基因的融合蛋白,用于研究该基因与睾丸功能的关系,还可能成为一种治疗男性睾丸相关疾病的生物药品。The purpose of the present invention is: in view of the fact that the human testis-specific protein kinase gene is a brand-new gene discovered by the inventor, the current human knowledge and understanding of this gene is limited to the scientific research work done by the inventor. Since this gene is related to the specific function of the testis, and it is low expressed in the embryo and highly expressed in the adult, it is likely to be related to the development of the testis, and its abnormal expression may affect male reproductive function, so the study of this gene can be used for: ① By preparing the fusion protein of the gene, it is used to study the relationship between the gene and testis function, and it may also become a biological drug for treating male testis-related diseases.
②制备特异性抗体:基因编码蛋白的特异性抗体是研究基因结构和功能的不可缺少的重要工具,人睾丸蛋白激酶基因编码蛋白的多克隆和单克隆抗体,可用作免疫组织化学染色、ELISA、免疫电镜、免疫共沉淀等多种根据免疫学原理设计的检测方法,可用于该基因编码蛋白在组织细胞中的定位和定量研究,也可用于各种生物样本(如血液、精液、尿液等)中的含量变化研究以及蛋白质-蛋白质相互作用研究等。因此,该抗体有可能用于制备与人睾丸特异蛋白激酶基因表达异常相关疾病诊断试剂盒,并有可能用于制备抗生育药物。② Preparation of specific antibodies: specific antibodies for gene-encoded proteins are an indispensable and important tool for studying gene structure and function. Polyclonal and monoclonal antibodies for proteins encoded by the human testis protein kinase gene can be used for immunohistochemical staining, ELISA , immunoelectron microscopy, immunoprecipitation and other detection methods designed according to immunological principles can be used for localization and quantitative research on the protein encoded by the gene in tissue cells, and can also be used for various biological samples (such as blood, semen, urine, etc.) etc.), research on content changes and protein-protein interaction research, etc. Therefore, the antibody may be used in the preparation of a diagnostic kit for diseases related to the abnormal expression of the human testis-specific protein kinase gene, and may be used in the preparation of antifertility drugs.
③制备基因诊断芯片:将功能基因用于制备基因诊断芯片是基因开发研究的一个重要方面,在疾病诊断(如男性不育、性功能低下)和药物筛选等方面均具有重要意义。本发明技术方案1.人睾丸特异的蛋白激酶基因融合蛋白的制备③Preparation of genetic diagnostic chips: The use of functional genes in the preparation of genetic diagnostic chips is an important aspect of gene development research, and is of great significance in disease diagnosis (such as male infertility, low sexual function) and drug screening. Technical solution of the present invention 1. Preparation of Human Testis-Specific Protein Kinase Gene Fusion Protein
以人睾丸特异的蛋白激酶基因开放阅读框的核苷酸序列与质粒pDESTTM15制备成GST-SP2-pDEST15表达质粒,在无NaCl的LB中30℃培养到0.5 OD600,经0.3M NaCl诱导后,超声粉碎后经GST亲和层析柱纯化,得到纯化的融合蛋白。2.人睾丸特异的蛋白激酶基因编码蛋白特异性多克隆抗体The nucleotide sequence of the open reading frame of the human testis-specific protein kinase gene and the plasmid pDEST TM 15 were used to prepare the GST-SP2-pDEST15 expression plasmid, cultured in NaCl-free LB at 30°C to 0.5 OD600, and induced by 0.3M NaCl , purified by GST affinity chromatography column after ultrasonic pulverization to obtain purified fusion protein. 2. Human testis-specific protein kinase gene-encoded protein-specific polyclonal antibody
取融合蛋白与载体蛋白KLH(Keyhole Limpet Hymocyanin)结合,经透析后再与完全/不完全佐剂(Complete/Incomplete Freund’sAdiuvant)等量混合,免疫新西兰兔(背部皮下注射),每隔3~4周激发注射一次,共三次,于三个月后取血分离血清。以免疫前动物血清作为对照做ELISA,测定各免疫兔血清中抗体滴度。筛选高滴度血清,进一步用抗原作竞争抑制免疫试验确定抗体的特异性。根据ELISA结果确定其用于免疫组织化学染色的稀释倍增数为1∶200~500。3.人睾丸特异的蛋白激酶基因编码蛋白特异性单克隆抗体Combine the fusion protein with the carrier protein KLH (Keyhole Limpet Hymocyanin), and then mix it with an equal amount of complete/incomplete adjuvant (Complete/Incomplete Freund's Adiuvant) after dialysis, and immunize New Zealand rabbits (subcutaneous injection in the back), every 3~ Inject once every 4 weeks for a total of three times, and blood was collected three months later to separate serum. ELISA was performed with the animal serum before immunization as a control, and the antibody titer in each immunized rabbit serum was determined. Screen high-titer sera, and further use the antigen as a competitive inhibition immunoassay to determine the specificity of the antibody. According to the results of ELISA, the dilution doublings for immunohistochemical staining were determined to be 1:200-500.3. Human testis-specific protein kinase gene-encoded protein-specific monoclonal antibody
取融合蛋白与载体蛋白KLH(Keyhole Limpet Hymocyanin)结合,经透析后再与完全/不完全佐剂(Complete/Incomplete Freund’sAdiuvant)混合,免疫Balb/C小鼠(腹腔内注射),隔周一次,连续2-3次,融合前静脉加强一次,用ELISA方法证实抗体的产生后,取脾脏分离脾细胞,然后与骨髓瘤细胞融合产生杂交瘤细胞。阳性克隆经多次亚克隆,直至获得分泌抗人睾丸特异的蛋白激酶抗体的单克隆杂交瘤细胞株。4.人睾丸特异的蛋白激酶基因用于制备睾丸功能基因表达芯片Combine the fusion protein with the carrier protein KLH (Keyhole Limpet Hymocyanin), and then mix it with complete/incomplete adjuvant (Complete/Incomplete Freund's Adiuvant) after dialysis, and immunize Balb/C mice (intraperitoneal injection), once every other week , 2-3 times in a row, and the vein was strengthened once before fusion. After confirming the production of antibodies by ELISA method, the spleen was taken to separate spleen cells, and then fused with myeloma cells to produce hybridoma cells. Positive clones were subcloned several times until a monoclonal hybridoma cell line secreting anti-human testis-specific protein kinase antibody was obtained. 4. Human testis-specific protein kinase gene used to prepare testis functional gene expression chip
(1)以获取的人睾丸蛋白激酶基因的核苷酸序列设计引物,扩增全长的人睾丸蛋白激酶基因序列,用作点膜的样品。(2)用英国BioRobotics自动点膜仪将标本点在8×12cm尼龙膜上,每一标本点2个点,每点的DNA量约几ng。;阳性对照8个housekeeping genes (a.ribosomal protein S9;b.Actin gamma;c.glyceraldehyde-3-phosphate dehydrogenase;d.hypoxanthinephosphoribosyltransferase 1;e.H.sapiens mRNA for 23KD highly basicprotein;f.ubiqnitin C;g.Phospholipase A2;h.ubiquitin carboxy I-ferminal esterase L I)。阴性对照加λ噬菌体DNA和P-blue质粒。(3)将含有该基因的芯片用于人睾丸特异的蛋白激酶基因缺失的诊断和药物筛选33p标记:(1) Design primers with the obtained nucleotide sequence of the human testis protein kinase gene, amplify the full-length human testis protein kinase gene sequence, and use it as a sample for spotting the membrane. (2) Use the British BioRobotics automatic film spotting instrument to spot the specimen on an 8×12 cm nylon membrane, 2 spots for each sample, and the amount of DNA in each spot is about a few ng. ; positive control 8 housekeeping genes (a.ribosomal protein S9; b.Actin gamma; c.glyceraldehyde-3-phosphate dehydrogenase; d.hypoxanthinephosphoribosyltransferase 1; eHsapiens mRNA for 23KD highly basicprotein; f.ubiqnitin C; g.Phospholipase A2; h. ubiquitin carboxy I-ferminal esterase L I). Negative control plus lambda phage DNA and P-blue plasmid. (3) The chip containing this gene is used for the diagnosis and drug screening of human testis-specific protein kinase gene deletion 33 p marker:
抽提待检标本mRNA或DNA,用Random Primer标记法标记待检标本mRNA或DNA,作为杂交的探针。Extract the mRNA or DNA of the sample to be tested, and use the Random Primer labeling method to label the mRNA or DNA of the sample to be tested as a probe for hybridization.
杂交:hybridization:
将点制好的尼龙膜标记探针杂交后,杂交炉(68℃)内烘干,用磷屏压片。信号扫描和分析:After hybridizing the prepared nylon membrane-labeled probes, dry them in a hybridization oven (68° C.), and press them with a phosphor screen. Signal Scanning and Analysis:
用记录仪分析杂交信号。根据杂交信号的强弱分析影响人睾丸激酶基因蛋白表达水平或人睾丸特异的蛋白激酶基因的缺失。Hybridization signals were analyzed with a recorder. According to the strength analysis of the hybridization signal, the expression level of human testis kinase gene protein or the deletion of human testis specific protein kinase gene is affected.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01113510 CN1319660A (en) | 2001-04-11 | 2001-04-11 | Human testis specific protein kinase gene coding protein |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01113510 CN1319660A (en) | 2001-04-11 | 2001-04-11 | Human testis specific protein kinase gene coding protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1319660A true CN1319660A (en) | 2001-10-31 |
Family
ID=4660231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 01113510 Pending CN1319660A (en) | 2001-04-11 | 2001-04-11 | Human testis specific protein kinase gene coding protein |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1319660A (en) |
-
2001
- 2001-04-11 CN CN 01113510 patent/CN1319660A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009039107A5 (en) | ||
| CN105548561B (en) | Diagnostic agent and diagnostic method for alzheimer's disease | |
| US20050176935A1 (en) | Dna dependent protein kinase catalytic subunit phosphorylation sites and antibodies thereto | |
| CN118515769B (en) | Anti-TPO mouse monoclonal antibody and preparation method and application thereof | |
| JP2003510053A (en) | Heparanase-2, a member of the heparanase protein family | |
| CN114456265B (en) | anti-HFABP monoclonal antibody and application thereof | |
| CN1319660A (en) | Human testis specific protein kinase gene coding protein | |
| CN1309138A (en) | Human testicular cytodifferentiation related protein gene coded protein | |
| US20090087842A1 (en) | Presynaptic protein cast | |
| CN1313342A (en) | Human testis lactate dehydrogenase A gene coded protein | |
| CN1318557A (en) | Human testicular specific protein-10 gene encoded protein | |
| CN1318559A (en) | Human sperm skelemin gene encoded protein | |
| CN1318554A (en) | Human testicular development specific protein-11 gene encoded protein | |
| CN1319665A (en) | Human testics kinesin 9 gene coding protein | |
| CN1318560A (en) | Human testicular specific protein-1 gene encoded protein | |
| CN1319662A (en) | Human testicular ubiquitin specific proteinase-10 gene coding protein | |
| CN1318562A (en) | Human testicular development specific protein-14 gene encoded protein | |
| CN1316434A (en) | Human specific protein kinase-15 gene coding protein | |
| CN1313340A (en) | Human sperm-specific protein 2 gene coded protein | |
| CN1382694A (en) | Human testis development specific protein-17 gene coding protein | |
| CN1309137A (en) | Human testicular gastrulation protein gene coded protein | |
| CN1318558A (en) | Human testicular development specific protein-12 gene encoded protein | |
| CN114316041B (en) | Preparation method of NLS-RAR alpha monoclonal antibody, rapid detection card based on antibody and preparation method of rapid detection card | |
| CN1344735A (en) | Human testicular development specific protein-19 gene encoding protein | |
| WO2012134039A1 (en) | Protein having antigen activity against liver flukes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |